Megestrol acetate is a medication used to treat certain types of cancer, like endometrial or breast cancer. It's sometimes used to help manage symptoms like loss of appetite or weight loss in patients with cancer. It's taken by mouth.
Every report comes from a Lived member, sent anonymously.
Have you tried Megestrol Acetate for Loss of Appetite?
Megestrol acetate is a prescription hormone medicine taken by mouth. It is a progestin, a man-made version of the hormone progesterone, and it has two quite different uses depending on the form. It was long sold under the brand name Megace, with a concentrated liquid called Megace ES, but those brands are no longer marketed in the US; megestrol is now available as generic tablets and liquids. The tablets are approved for advanced breast cancer and advanced cancer of the lining of the uterus (endometrial cancer) when the disease has come back, has spread or cannot be removed with surgery. This is palliative treatment, meaning it aims to ease symptoms and control the illness rather than cure it, and it is not meant to replace surgery, radiation or chemotherapy when those are appropriate. The liquid (oral suspension) is approved for severe appetite loss, wasting (cachexia, a loss of weight and muscle that eating more does not easily reverse) or unexplained significant weight loss in people with AIDS. Doctors also sometimes prescribe it off-label for appetite and weight loss in advanced cancer. Before it is started for weight loss, treatable causes such as infections, digestive problems that block absorption of food, hormone disorders, kidney disease or mental health conditions should be looked for and addressed. It is not meant to prevent weight loss in someone who has not lost weight.
Megestrol acts like progesterone in the body. Some breast and endometrial cancers grow in response to female hormones, and changing that hormonal signal can hold these tumors back. Breast cancers whose cells carry estrogen or progesterone receptors (proteins that let a cell respond to those hormones) are more likely to respond. How megestrol increases appetite is not known. People taking it often feel hungrier and eat more, and weight tends to rise as a result. Megestrol also has effects resembling cortisol, the body's main stress hormone, which help explain some of its more serious side effects, including higher blood sugar and suppression of the adrenal glands.
Megestrol is taken by mouth at around the same time or times each day. Tablets for cancer are usually taken in several doses spread through the day, and at least two months of continuous treatment is generally needed to judge whether they are working. The liquid comes in two strengths that are not interchangeable. The regular suspension (40 mg per mL) is typically started at 20 mL a day for AIDS-related weight loss, while the concentrated suspension (125 mg per mL, formerly sold as Megace ES) is typically started at 5 mL a day. A volume measured for one strength would be the wrong dose of the other, so check that the pharmacy label matches the prescription and switch only on the prescriber's instructions. Shake the bottle well before each dose and use a proper measuring device rather than a kitchen spoon. The concentrated liquid can be taken with or without food.
Increased appetite and weight gain are expected, and are the purpose of treatment when megestrol is used for weight loss. Other common effects include nausea, diarrhea, gas, rash, weakness, trouble sleeping, higher blood pressure and fluid retention, such as swollen ankles. Men may have erectile problems or lower sex drive, and women may have unexpected vaginal bleeding even after periods have become irregular. Megestrol raises the risk of blood clots, which can be fatal. Pain, swelling or warmth in one leg can mean a clot in a leg vein and should be reported to the care team right away. Sudden shortness of breath or chest pain can mean a clot has traveled to the lungs (pulmonary embolism) and needs emergency care. Megestrol can also raise blood sugar, causing new diabetes or making existing diabetes harder to control. Extreme thirst, urinating much more often or unusual hunger beyond the expected appetite boost are reasons to contact the care team promptly. People who already have diabetes may need closer glucose checks and changes to their diabetes medicines.
Long-term megestrol can quietly suppress the adrenal glands, which make cortisol, the hormone the body relies on to cope with illness, injury and surgery. Adrenal insufficiency (too little cortisol) can then develop while taking megestrol or after stopping it, particularly during an infection or other serious illness. Nausea, vomiting, dizziness, weakness or low blood pressure in someone on long-term megestrol, or recently off it, deserves a prompt call to the care team, because unrecognized adrenal insufficiency can be life-threatening. Surgeons, dentists and hospital staff should know about megestrol use, since extra steroid medicine may be needed during surgery or serious illness. Megestrol may harm a developing baby. The liquid should not be used during pregnancy, and anyone who could become pregnant should have a pregnancy test before starting and use effective contraception during treatment with either form, even if periods become irregular. Breastfeeding is not recommended while taking it. People with a history of blood clots, stroke, diabetes or kidney disease need their risks weighed carefully, because the drug is cleared mainly by the kidneys and these conditions make its main harms more likely or more serious. Megestrol can raise the INR, the clotting test used to adjust warfarin (a blood thinner), so people on warfarin need closer INR checks. It also lowers blood levels of the older HIV medicine indinavir, so the full medication list, including supplements, should be reviewed with the prescriber or pharmacist. Adults 65 and older are generally advised not to take megestrol for appetite and weight loss.
When megestrol is used for appetite and weight, appetite usually improves before weight changes. Studies show it improves appetite and leads to slight weight gain compared with no treatment, but it has not worked better than other drug options, and in trials people taking it had more swelling, blood clots and deaths. For weight loss with advanced cancer, specialist guidance treats it as one option that may be tried alongside nutrition advice, not as a standard treatment, so it is worth agreeing at the start on what benefit would make it worth continuing. For breast or endometrial cancer, the care team judges the response over a couple of months using examinations, scans or tests. In either use, follow-up usually includes checks of weight, blood pressure, swelling and blood sugar, plus INR for anyone on warfarin. After long-term use, stopping should be planned with the care team rather than done suddenly. Because the adrenal glands may be slow to recover, illness, vomiting or unusual weakness after stopping still deserves attention.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Megestrol Acetate, what you've noticed, or ask the community a question.